Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 February 2012: Public Health  

How well do anthropometric indices correlate with cardiovascular risk factors? A cross-sectional study in Croatia

Davorka Vrdoljak ABCDEF , Biserka Bergman Marković ACE , Ksenija Kranjčević AB , Dragica Ivezić Lalić AB , Jasna Vučak AB , Milica Katić A

DOI: 10.12659/MSM.882451

Med Sci Monit 2012; 18(2): PH6-11

0 Comments

Background

AIMS:

To assess the correlation between AI of obesity and CV factor, total CV and stroke risk scores in a nationally representative sample of the Croatian adult population registered with general practitioners (GP). Hypotheses were that we would observe differences in obesity and overweight across regions of Croatia (coastal/inland) and by settlement size (urban/rural) and a higher predictive value of WtHR for CV risk factors, total CV and stroke risk compared to others (BMI, WC, WHR).

Material and Methods

DESIGN:

This is a cross-sectional part of the CRISIC-fm study, conducted from May to July 2008 in 59 GP practices in Croatia. The study population comprised 2467 participants aged ≥40.

This was a 2-stage study: 1. a representative sample of GP practices was selected randomly by 4-stage stratified sampling method [county, region (coastal, inland, urban, rural and number of insured people in the GP’s care in 2007]. The principal investigators of each stratum were initially selected from a random list. If the principal investigator refused to participate, the next GP on the list was invited. The list was created according to the location closest to the principal investigator, in the same stratum. GPs enrolled the first 55 consenting patients aged ≥40 (one per day), who visited the practice during the study period for whatever reason. Exclusion criteria were communication disability (dysphasia, aphasia), severe dementia or mental illness, and disease with estimated life expectancy of less than 6 months. The study was approved by the Research Ethics Committee of the Medical School of Zagreb.

All participants gave written consent.

QUESTIONNAIRES AND MEASUREMENTS:

A 140-item CRISIC-fm standardized questionnaire was developed for the purpose of the project and was validated in a pilot study. Participants were interviewed (face-to-face) by trained researchers. The measures analyzed were: height and weight (the mean of 2 measurements on standardized anthropometric scales), waist and hip circumference (by plastic coated, non-elastic tape), and seated arterial blood pressure (the mean of 2 measurements performed by mercury sphygmomanometer).

Blood samples were taken for biochemical analysis (total cholesterol, HDL and LDL, triglycerides, fasting blood glucose). Diagnostic criteria of arterial hypertension, dyslipidemia and glycemia were based on the current guidelines of professional societies (Box 1). The expected 10-year risk of fatal CV disease in primary prevention was calculated using the SCORE chart for high risk countries and for stroke according to Framingham risk score [13,14].

BIAS:

Standard error of measurement was reduced by using identical standardized measuring instruments at all locations and by repeated measurements (×2). Numerical data verification and logical control of systematic errors were performed.

STATISTICAL ANALYSIS:

Descriptive statistical methods were used to describe participants’ demographic characteristics. The χ2 test was used to measure associations between 2 categorical variables (Fisher’s exact test for 2×2 tables). Logistic regression analysis determined the odds ratio (OR) and significance of the independent contribution of each AI in predicting CV risk. Sensitivity and specificity of AI as an area under a curve (AUC) for each CV risk factor were determined by receiver operating characteristic (ROC) analysis. All statistical methods were performed using SPSS for Windows (11.5, SPSS Inc., Chicago, IL, 2002), at a 95% level of significance (P<0.05).

Results

We obtained data from 2467 participants (61.9% women, 38.1% men; 69.3% inland, 30.7% coastal; 26.0% rural, 74.0% urban). The response rate of GPs was 71% and response rate of participants was 78%. Considering AI, 1918 (80%) participants had an increased waist circumference, 225 (30.4%) had increased WHR, 1015 (42.1%) were overweight, 875 (36.3%) were obese, and 1933 (83%) had increased WtHR according to pre-ordained criteria.

In comparing coastal/inland and urban/rural, there was a difference in BMI across regions and by the settlement size (Table 1). Chi-square test showed fewer obese people found in the coastal than in the inland areas (P=0.032). In rural areas there were more obese people (P<0.001), and more individuals with increased WHR (P=0.004) and increased WtHR (P<0.001) than in urban areas.

Systolic blood pressure ≥140mm Hg occurred more often in urban areas (P<0.001), and diastolic blood pressure >90 mm Hg occurred more often in inland (P<0.041) areas. There was no difference in dyslipidemia, while hyperglycemia was found more often in the inland population (P<0.001) (Table 2). Total CV risk according to SCORE did not differ across the regions according to urbanization, whereas the Framingham risk score was higher in inland than in coastal areas (P<0.001), and was higher in urban areas than in rural settlements (P<0.001).

For all logistic regressions we made adjustments for age, sex, physical activity and smoking. Among the AIs, calculated BMI >30 kg/m2 proved to be the best predictor for hypertension, diabetes and dyslipidemia (Table 3) and was a significant predictor for all CV risks in both regions, except for diabetes in the coastal area. WtHR had a significant predictive value for 2 CV risks, hypertension and dyslipidemia (Table 3), and was a significant predictor for all 3 CV risks in the coastal area, but only for hypertension in the inland area. Considering the settlement size, WtHR proved to be a good predictor for all 3 CV risks in urban areas, while in rural areas it was only significant for hypertension. None of the anthropometric indices showed any statistically significant independent contribution to the total CV risk by SCORE, but BMI and WC did for stroke risk according to Framingham (Table 3).

ROC analyses indicated WtHR is a better predictor of hypertension and dyslipidemia than other indices. However, for total CV risk according to SCORE and stroke risk according to Framingham, WHR was the best predictor (Table 4).

Discussion

LIMITATIONS:

There are 2 main limitations to this study. First, the sample of subjects was patients registered with a GP, which does not entirely correspond to the general population sample (those without health insurance or who do not visit a GP for other reasons could not be included). Second, the usual limitation of every cross-sectional study is the existence of only a possible correlation between AI and CV risk factors, since the causal connection cannot be directly determined by such a study design.

Conclusions

The prevalence of general and central obesity is high in the population registered with a GP in Croatia. By combined use of inexpensive and simple anthropometric indices (BMI for general and WtHR for abdominal obesity) GPs could better identify individuals at increased risk for CV events. Well-timed lifestyle and pharmacological intervention when indicated could prevent new and recurrent CV events in the population under the care of GPs.

References

1. , Curbing the obesity epidemic: Lancet, 2006; 367; 1549, pmid: 16698389

2. Kern J, Strnad M, Čorić T, Vuletić S, Cardiovascular risk factors in Croatia: struggling to provide the evidence for developing policy recommendations: BMJ, 2005; 331; 208-10, pmid: 16037458

3. Jelčić J, Koršić M, Obesity as medical and public health problem: Liječn Vjesn, 2009; 131; 279-85

4. Fontaine KR, Redden DT, Wang C, Years of life lost due to obesity: JAMA, 2003; 289; 187-93, pmid: 12517229

5. Haveman-Nies A, de Groot LC, van Staveren WA, Dietary quality, lifestyle factors and healthy aging in Europe: the SENECA stdy: Age nad Ageing, 2003; 32; 427-34

6. Croatian National Institute of Public Health: Croatian Health Service Yearbook 2006, 2007, Zagreb

7. Muller-Nordhorn J, Binting S, Roll S, Willich SN, An update on regional variation in cardiovascular mortality within Europe: Eur Heart J, 2008; 29; 1316-26, pmid: 18256043

8. Wang Y, Rimm EB, Stampfer MJ, Comparision of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men: Am J Clin Nutr, 2005; 81; 555-63, pmid: 15755822

9. National Institutes of Health, Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report: Obes Res, 1998; 6(Suppl 2); 51S-209S, pmid: 9813653

10. World Health Organization, Obesity: preventing and managing the global epidemic: WHO Technical Report Series no. 894, 2000, Geneva, WHO

11. Despres JP, Lemieux I, Abdominal obesity and the metabolic syndrome: Nature, 2006; 444; 881-87, pmid: 17167477

12. Lee CMY, Huxley RR, Wildman RP, Woodward M, Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis: J Clin Epidemiol, 2008; 61; 646-53, pmid: 18359190

13. Conroy RM, Pyorala K, Fitzgerald AP, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project: Eur Heart J, 2003; 24; 987-1003, pmid: 12788299

14. Wolf PA, D’Agostino RB, Belager AJ, Kanel WB, Probabilty of stroke: a risk profile from Framingham study: Stroke, 1991; 22; 312-18, pmid: 2003301

15. Hauner H, Bramlage P, Losch C, Prevalence of obesity in primary care using different anthropometric measures-results of the German Metabolic and Cardiovascular Risk Project (GEMCAS): BMC Public Health, 2008; 8; 282-94, pmid: 18694486

16. World Health Organisation (WHO, 1998): Obesity: Prevention and managing the global epidemic, Report of a WHO Consultation on Obesity. WHO/NUT/NCD/98.1, Geneva

17. Yusuf S, Hawken S, Ounpuu S, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study: Lancet, 2004; 364; 973-52

18. , Excecutive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluationa and tretmant of high blood cholesterol in adults (Adult Treatment panel III): JAMA, 2001; 285; 2486-97, pmid: 11368702

19. Croatian National Institute of Public Health: Croatian Health Service Yearbook 2008, 2009, Zagreb

20. Chen L, Peters A, Magliano DJ, Anthropometric measures and absolute cardiovascular risk estimates in Australian Diabetes, Obesity and Lifestyle (AusDiab) Study: Eur J Cardiovasc Prev Rehabil, 2007; 14; 740-45, pmid: 18043293

21. Wang Z, Rowley K, Wang Z, Anthropometric indices and their relationship with diabetes, hypertension and dyslipidemia in Australian Aboriginal people and Torres Strait Islanders: Eur J Cardiovasc Prev Rehabilit, 2007; 14; 172-78

22. Ho SC, Chen YM, Woo JLF, Association between simple anthropometric indices and cardiovascular risk factors: Int J Obes, 2001; 25; 1689-97

23. Huang KC, Lin WY, Lee LT, Four anthropometric indices and cardiovascular risk factors in Taiwan: Int J Obes, 2002; 26; 1060-68

24. Schneider HJ, Glaesmer H, Klotsche J, Accuracy of anthropometric indicators of obesity to predict cardiovascular risk: J Clin Endocrinol Metab, 2007; 92; 589-94, pmid: 17105840

25. Yalcin BM, Sahin EM, Yalcin E, Which anthropometric measurements is most closely related to elevated blood pressure?: Fam Pract, 2005; 22; 541-47, pmid: 15964872

26. Panagiotakos DB, Chrysohoou C, Pitsavos C, Hierarchical analysis of anthropometric indices in the prediction of 5-year incidence of hypertension in apparently healthy adults: The ATTICA study: Atherosclerosis, 2009; 206; 314-20, pmid: 19368924

27. De Koning L, Merchant AT, Pogue J, Anand S, Waist circumference and waist-to hip ratio as predicors of cardiovascular events: meta-regression analysis of prospective studies: Eur Heart J, 2007; 28; 850-57, pmid: 17403720

28. Gelber RP, Gaziano M, Orav J, Measures of obesity and cardiovascular risk among men and women: J Am Coll Cardiol, 2008; 52; 605-15, pmid: 18702962

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750